Content
Royalty Pharma Merits Private Equity Drug Discount
Article By:
Lipper Alpha Insight
Read
Wednesday, June 17, 2020 4:42 AM EDT
Prescription drug pricing is a hot-button issue among U.S. voters, and a sweeping win by the Democrats could bring price controls – which would especially hurt indebted players like Royalty.
The Week Ahead In Biotech: FDA Decisions In The Cards For Merck, Epizyme, Evoke, And Ultragenyx
Article By:
Benzinga
Read
Sunday, June 14, 2020 3:13 PM EDT
Biotech stocks came under pressure along with the broader market in the week that ended June 12, as a worsening pandemic situation and its impact on the economy led to an across-the-board sell-off in the global markets.
In this article: MRK, EVOK, RARE, EPZM Also: AZN, GILD, BMY, SNY, RPRX, CELG, PRQR, NBRV, CBIO, UROV, CNTG
Building Products Maker Azek Surges In Debut
Article By:
The Fly
Read
Sunday, June 14, 2020 2:18 PM EDT
After opening higher, building products maker Azek ended its first trading day up over 18%. The company raised about $765 million in the biggest initial public offering of the week.
In this article: RNA Also: BAC, GS, WFC, VXX, JEF, TREX, CS, LLY, COWN, SIVBQ, JPM, MS, EVR, RPRX, ADCT
Week In Review: Suzhou Innovent Announces $2 Billion Immunotherapy Collaboration With Roche
Article By:
ChinaBio® Today
Read
Saturday, June 13, 2020 1:32 PM EDT
Suzhou Innovent Bio formed a far-reaching R&D collaboration with Roche that has a potential value of over $2 billion. Roche will have an option to license each product for ex-China development and commercialization.
Insurtech Lemonade Files For IPO; Seeks To Raise $100 Million
Article By:
Donna Fuscaldo
Read
Tuesday, June 9, 2020 12:10 PM EDT
Lemonade, the insurance start-up hailing out of New York, is preparing to launch an initial public offering.
In this article: LMND
Week In Review: China Life Science Companies Raise Nearly $1 Billion Led By Legend's $424 Million US IPO
Article By:
ChinaBio® Today
Read
Saturday, June 6, 2020 1:44 PM EDT
In a successful debut offering, Nanjing Legend Biotech priced its US IPO above the expected range at $23 per ADS, raising $424 million. The company's ADS's climbed 60% higher to $36.60, giving Legend a market capitalization of nearly $5 billion.
JDE Peet’s IPO: Classic Story, Classic Investment Case
Israeli Startup Deal Digest – May 2020
Article By:
Shelly Hod Moyal
Read
Wednesday, June 3, 2020 6:34 AM EDT
Here is last month's summary of corporate developments in the Israeli startup market. This May we tracked 28 announced deals totaling at approximately $582.5 Million, and 3 exits of $1.085 Billion.
In this article: INTC
Applying Complexity Theory To Valuation
Article By:
Karl Sjogren
Read
Wednesday, June 3, 2020 3:42 AM EDT
Complexity theory studies how simple changes affect complex systems. Valuation plays a key role in capitalism, a complex system.
Making Sense Of Pandemic Valuations
Article By:
Karl Sjogren
Read
Monday, June 1, 2020 2:45 AM EDT
With the pandemic induced havoc, how is that the stock market is not down more? And what effect will the downturn have on the valuation of startups? This is the first of three articles that discuss valuations and capital structures.